BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240201T120000
DTEND;TZID=Europe/Paris:20240201T130000
DTSTAMP:20240130T100201Z
CREATED:20231121T152925Z
LAST-MODIFIED:20240130T100201Z
UID:45271-1706788800-1706792400@www.bricbordeaux.com
SUMMARY:BRIC COMSOL technology seminar
DESCRIPTION:This event is part of the technology seminar organized by our BRIC unit (BoRdeaux Institute of onCology)\, in collaboration with COMSOL France. \nThis hybrid format seminar is available online and is open to scientists from the Biological and Medical Sciences Department (SBM) at the University of Bordeaux. \nPresentation by Fatma Khannous\, Applications Engineer at COMSOL France. \nObjective:\nPresent the benefits of digital simulation and virtual experimentation in the field of oncology through concrete case studies. Provide an overview of the COMSOL Multiphysics graphical interface and the functionalities relevant to R&D challenges in this sector. \nMethod :\nThe presentation will consist of an introduction to numerical simulation with COMSOL Multiphysics and its application to cancer research\, illustrated by a demonstration in the software’s graphical interface. \nIndicative content :\n– Introduction to numerical simulation\n– User cases in the field of oncology\n– Demonstration of COMSOL Multiphysics on a model of active ingredient transport in biological tissues.\nSeveral topics will be covered in the presentation\, including simulation of pharmacokinetics\, molecule and cell transport (advection\, diffusion\, migration)\, and simulation of tumor ablation techniques. \nEquipment and logistics :\nHybrid format in the BBS conference room\, 2 rue Dr Hoffmann Martinot Bordeaux \nRegister before January 31st to follow the event online via this link
URL:https://www.bricbordeaux.com/en/event/bric-comsol-technology-seminar/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/11/cosmol-2024-02.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240203
DTEND;VALUE=DATE:20240204
DTSTAMP:20240111T162359Z
CREATED:20240111T162359Z
LAST-MODIFIED:20240111T162359Z
UID:45340-1706918400-1707004799@www.bricbordeaux.com
SUMMARY:Clinical science symposium 2024 – Institut Bergonié - World Cancer Day
DESCRIPTION:TheInstitut Bergonié is celebrating the 1st century of the fondation of the first tertiary cancer center in France (1923). This event will be clotured by a symposium of high scientific level dedicated to oncologists that will be held in Bordeaux\, in France. \nDuring this symposium\, several international Key Opinion Leader’s will share with our young colleagues their vision regarding the future of cancer. We look forward to seeing you on Saturday February 3\, 2024 from 9 a.m. at Hangar 14\, on the docks of Bordeaux. \nSpeakers: \nPr David Cameron\, Professor of Oncology and Director of Cancer Services\, NHS Lothian at University of Edinburgh\nPr Eric Deutsch\, Head of Department of Radiotherapy\, Villejuif\, France\nPr Antoine Italiano\, Head of Department of Medicine\, Bordeaux\, France (head of the team 9 – SARCOTARGET)\nDr Ira Mellman\, VP Cancer Immunology\, Genentech\, San Francisco\, USA\nPr Jean-Philippe Metges\, Associate University Professor in Oncology with a specialization in Medical Oncology University of Western Brittany\nDr Jordi Remon\, CIOCC Barcelona\, Espagne\nPr Dominik Ruettinger\, Global Head Research and Early Development Oncology\, Bayer\, Berlin\, Allemagne \nRegister now by clicking HERE. \nDiscover the complete program by clicking HERE. \nThree good reasons to participate : \n\nMeet international experts : renowned speakers from different countries will share their knowledge and innovative advances in oncology.\nMeet your peers : discuss with your peers the challenges and issues of oncology\, but also your experiences and your daily practices.\nBenefit from registration for continuing education : your registration can be taken care of by your continuing education service.
URL:https://www.bricbordeaux.com/en/event/clinical-science-symposium-2024-institut-bergonie-world-cancer-day/
LOCATION:Hangar 14\, 115 Quai des Chartrons\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/01/clinical-symposium-institut-bergonie-03-02-2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240206T170000
DTEND;TZID=Europe/Paris:20240206T180000
DTSTAMP:20240201T153739Z
CREATED:20240125T084752Z
LAST-MODIFIED:20240201T153739Z
UID:45416-1707238800-1707242400@www.bricbordeaux.com
SUMMARY:BRIC prestige seminar - Dr Olivier Delattre
DESCRIPTION:For the first edition of the prestige seminars organized by our BRIC unit\, we are delighted to welcome Dr Olivier Delattre\, Research Director at Curie Institute\, head of the Unit U830 “Cancer\, Heterogeneity\, Instability and Plasticity” (CHIP) and “Grand prix INSERM 2022” \nWe will take advantage of his visit to organize meetings with researchers and students from our unit. \nSeminar at 5pm on Tuesday February 6\, 2024\, BBS conference room\, 2 rue Dr Hoffmann Martinot. \nDr. Olivier Delattre is MD-PhD\, trained in pediatric oncology. He is Research Director at Inserm and heads the Research Unit U830 “Cancer\, Heterogeneity\, Instability and Plasticity” (CHIP) and the research team “Diversity and plasticity of children tumours” (DePiCT) at the Institut Curie (Paris). He has also created the Somatic Genetics Unit\, aimed to transfer research results to the clinic\, and heads the “Genetic and Biology of Cancer” department at the Institut Curie. He also leads the SIREDO Center (Care\, Innovation\, Research in Oncology of Children\, Adolescent and Young Adults) at the Institut Curie\, gathering clinicians and researchers to accelerate the development of new therapeutic strategies for pediatric cancers. His lab identified some key genetic alterations in Ewing sarcoma\, rhabdoid tumors\, neuroblastoma as well as in various sarcomas\, and also the Neurofibromatosis type 2 (NF2) tumour suppressor gene. His lab investigates the functional consequences of these alterations in tumour development\, and has established cellular and animal models. His current fields of interest are the study of genetic alterations associated with pediatric cancers\, the study of pediatric cancers cells-of-origin and the mechanisms of cancer cells phenotypic plasticity. Dr Delattre has published more than 400 papers\, many of them in the most prestigious journals such as Nature\, Nature Genetics\, Nature Medicine\, Cancer Cell\, Molecular Cell\, New England Journal of Medicine…\, with an H-index of 102. He received numerous awards including the “Association pour la Recherche sur le Cancer (ARC)-Leopold Griffuel” award in 2016\, the “Grand Prix de la Recherche Inserm” in 2022\, and the “American Association for Cancer Research (AACR)-St. Baldrick’s Foundation” Award for Outstanding Achievement in Pediatric Cancer Research in 2023. He is an elected member of EMBO (European Molecular Biology Organization).           \n🎤 Ewing sarcoma: From genetics to epigenetics and immunology. \nEwing sarcoma is a bone cancer mostly observed in children and young adults. The EWSR1::FLI1 gene fusion (Nature 1992) is a key driver of this malignancy ( J. Clin. Oncol.  1996\, 2010; Cancer Discov. 2014). It completely reprograms the Ewing cell-of-origin (Cancer Cell 2007; Cancer Res. 2021) through direct binding at GGAA microsatellites and subsequent transformation of these sequences into bona fide enhancers (PLoS One 2009; Nature Genetics 2015; Nature Medicine 2017; Nat Rev Dis Primers 2018). Activation of GGAA microsatellites also leads to specific transcription of intergenic regions (Cancer Cell 2021\, 2022; Mol Cell\, 2022; Cell Rep. 2022). Recent data of the laboratory indicate that some of these transcripts can be translated thus leading to important applications for immunotherapy.    \n  \n🤝 If scientists outside the BRIC unit would like to meet Dr Olivier Delattre\, please contact Thomas Mathivet: thomas.mathivet@inserm.fr
URL:https://www.bricbordeaux.com/en/event/bric-prestige-seminar-dr-olivier-delattre/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/01/seminaire-prestige-bric-olivier-delattre-2024-02-06.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240215T133000
DTEND;TZID=Europe/Paris:20240215T170000
DTSTAMP:20240212T142041Z
CREATED:20240212T142041Z
LAST-MODIFIED:20240212T142041Z
UID:45635-1708003800-1708016400@www.bricbordeaux.com
SUMMARY:MIRCADE laboratory open house - International Childhood Cancer Day - February 15\, 2024
DESCRIPTION:Team 6 – MIRCADE (Methods and Innovations for Childhood Cancer Research) is opening its laboratory to the public on Thursday afternoon\, February 15\, to mark International Childhood Cancer Day.\nThe discussions can also be followed remotely by videoconference. \nContact : christophe.grosset@inserm.fr ; Tél: 05 57 57 46 30 \nZoom link: https://u-bordeaux-fr.zoom.us/j/82475246111\nID de réunion: 824 7524 6111\,\nCode secret: 931880 \n 
URL:https://www.bricbordeaux.com/en/event/mircade-laboratory-open-house-international-childhood-cancer-day-february-15-2024/
LOCATION:site Carreire Université de Bordeaux\, 146 rue Leo Saignat\, Bordeaux\, 33076\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/02/vignette.jpg
END:VEVENT
END:VCALENDAR